期刊文献+

高通量血液透析的新认识 被引量:13

在线阅读 下载PDF
导出
作者 季大玺
出处 《中国中西医结合肾病杂志》 2005年第10期559-562,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
作者简介 季大玺,男,1951年11月生,江苏人.南京大学医学院教授,博士生导师.任中华医学会江苏省分会第七届理事,江苏省肾脏病学会主任委员,中国透析移植协会委员,国家药品监督局药品审评专家,中华医院管理学会血液净化管理分会常委,《中国血液净化》杂志副主编,《肾脏病与透析肾移植杂志》等5种杂志编委.从事肾脏病及血液净化专业20年,承担全军“九五”及“十五”科研课题.曾获国家及军队科技进步奖10余项(其中国家科技进步三等奖1项、军队科技进步二等奖2项及医疗成果二等奖1项为第一承担者).主编《连续性血液净化》,参加《肾脏替代治疗学》及《现代肾脏病》等9部专著编写工作;发表学术论文90余篇,其中第一作者40余篇,SCI收录1篇.为享受国务院政府特殊津贴专家.
  • 相关文献

参考文献26

  • 1Jacobs C,Kjellstrand CM, Koch KM,et al.Keplacement of renal function by dialysis.4th Revised Edition, Mrtherland: Lluwer Academic publisher,1996.432.
  • 2Ley poldt JK,Cheung AK,Clark WR,et al.Characterization of low and high-flux dialyzers NIH HEMO study:Interim report(Abstract). J Am Soc Nephrol,1996,7:1518.
  • 3Klinkmann H,Vienken J.Membranes for dialysis.Nephrol Dial Transplant,1995,10(Suppl 3):39-45.
  • 4龚德华,季大玺,谢红浪.高通量透析器复用的研究[J].医学研究生学报,2000,13(5):307-310. 被引量:26
  • 5龚德华,季大玺,谢红浪.高通量透析器复用效果的临床观察[J].中华肾脏病杂志,2001,17(1):49-50. 被引量:34
  • 6Leto E,Bilal F,Osmic I.Efficiency of high-flux dialysis in removal of beta-microglobulin.Med Ash,2001,55(4):225-226.
  • 7Schiffl H,Fischer R,Lang SM,et al.Clinical manifestations of AB-anyloidosis:effects of biocompatibility and flux. Nephrol Dial Transplant,2000,15(6):840-845.
  • 8Kucharska E,Stompor T,Sulowicz W,et al.Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry.Przegl Lek,2000,57(6):334-339.
  • 9Lugon JR,Andre ME,Duarte ME,et al.Effects of in center daily hemodialysis upon mineral metabolism and bone disease in and-stage renal disease patients.Sao Paulo Med J,2001,119(3):105-109.
  • 10龚德华,季大玺,陈惠萍,谢红浪,徐斌,刘芸,黎磊石.高通量维持性血液透析患者甲状旁腺素水平及骨代谢的变化[J].肾脏病与透析肾移植杂志,2001,10(4):317-321. 被引量:85

二级参考文献15

  • 1余颂涛,陈伟.人血内中分子量相关物质的测定方法[J].中华肾脏病杂志,1989,5(3):163-164. 被引量:3
  • 2[10] Ringoir S: An update on uremic toxins[J]. Kidney Int,1997,52(s62):s2-s4.
  • 3[11] Rosemary O,Brian PS,Richard AW,et al. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not β2-microglobulin removal[J]. Am J Kid Dis,1997,30(4):501-506.
  • 4[1] Sethi D, Gower PE.β2-microglobulin levels, dialysis arth-ropathy and the effect of dialyzer membrane[J]. Nephrol Dial Transplant,1988,3:768-772.
  • 5[2] Caverle Y,Simon P,Ang KS,et al. Serum β2-microglobulin levels in hemodialysis uremia depending on permeability of dialysis membranes[J]. Kidney Int,1987,31:229(abstrac).
  • 6[3] Maidment J,Peter SJ. The dialysis prescription: reuse[J]. Am J Nephrol,1996,16:52-59.
  • 7[4] Petersen J,Moore RM,Kaczmarek RG,et al. The effects of reprocessing cuprophane and polysulfone dialyzers on β2-microglobulin removal from hemodialysis patients[J]. Am J Kidney Dis,1991,17(2):174-178.
  • 8[5] Diaz RJ,Washburn S,Cauble L,et al. The effects of dialyzers reprocessing on performance and β2-microglobulin removal using polysulfone membranes[J]. Am J Kidney Dis,1993,21(4):405-410.
  • 9[6] Westhuyzen J,Foreman K,Battistutta D,et al. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients[J]. Am J Nephrol,1992,12:29-36.
  • 10[7] Kerr PG,Argiles A,Canaud B,et al. The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic acid on β2-mecroglobulin removal in hemodiafiltration[J]. Am J Kidney Dis,1992,19(5):433-438.

共引文献126

同被引文献120

引证文献13

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部